OR WAIT null SECS
August 28, 2018
Preliminary survey results rank the United States, Germany, and Japan as tier-one nations for bioprocessing performance and potential.
August 14, 2018
Pharmaceutical scientist association announces upcoming term’s board of directors.
August 09, 2018
The Alliance for Regenerative Medicine’s (ARM) report highlights major trends and metrics from the 2018 second quarter in the regenerative medicines sector.
August 06, 2018
Boehringer Ingelheim joins Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, and Imperial Innovations to form a partnership for developing a new gene therapy to treat cystic fibrosis.
August 02, 2018
Frustrated by slow market adoption, Gottlieb maps out new plan for biosimilar competition.
July 27, 2018
Waters’ acquisition of Prosolia’s DESI technology boosts its mass spectrometry imaging portfolio.
July 19, 2018
In launching FDA’s Biosimilar Action Plan, Gottlieb takes innovator companies to task for delaying competitive biosimilar products.
July 18, 2018
AbbVie will grant Mylan license to launch a biosimilar to AbbVie’s Humira.
July 11, 2018
Pfizer creates separate business units for innovator medicines, generic drugs, and consumer products.
July 03, 2018
Biogen will pay Samsung BioLogics approximately $700 million to increase its stake in Samsung Bioepis to approximately 49.9%.